Subfoveal Choroidal Neovascularization (CNV)
1 clinical trials · Condition
◉ Watch Subfoveal Choroidal Neovascularization (CNV)
| Record | Firm | Date |
|---|---|---|
| Safety and Tolerability of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (NCT00504959) | Novartis | 2007-07-01 |
Track Subfoveal Choroidal Neovascularization (CNV) automatically
Every clearance here is in the API, with alerts when new ones post.